BACH1 and lung cancer: In lung adenocarcinoma, the loss of keap1 and subsequent Nrf2 activation-induced metastasis through the accumulation of Bach1, and this process was related to a reduction in the survival rate of patients with lung cancer in a heme oxygenase-1-dependent manner.